Clinical Trial Update: MoMa Signature During Granulomatosis

View source ↗

Summary

A clinical trial update for MoMa Signature During Granulomatosis (NCT05916638) indicating ongoing recruitment for studies in sarcoidosis and tuberculosis, spons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoidosis
• Tuberculosis

Drugs mentioned

• MoMa Signature

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Sarcoidosis, Tuberculosis | Status: RECRUITING